The Stroke Research Center Bern has been founded in 2020 at the University of Bern from the Departments of Neurology, Neurosurgery and the Institute of Diagnostic and Interventional Neuroradiology. Its goal is to provide a high-level environment to catalyze research and support young researchers in stroke medicine.
Paper of the month - Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
This study includes 78 patients with thrombotic thrombocytopenic syndrome and cerebral venous thrombosis after Covid-19 vaccination from multiple countries on 4 continents. Most (776/78) received the AstraZeneca vaccine. Mortality was very high initially at 62% but improved to 42% after the syndrome became better known, platelet transfusions were avoided, and non-heparin anticoagulants were given.